Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis

Author： Moteshafi Hoda   Zhornitsky Simon   Brunelle Sarah   Stip Emmanuel  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.35, Iss.10, 2012-10, pp. : 819-836

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders:: A Meta-Analysis

By Baldessarini Ross J.  

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1183-1183

Adis International

Access to resources Recommend Favorite

Olanzapine in Schizophrenia and Affective Disorders

By Undurraga Juan  

Drug Safety, Vol. 35, Iss. 12, 2012-12 ,pp. : 1185-1186

Adis International

Access to resources Recommend Favorite

Cost Analysis of the Treatment of Schizophrenia in the UK: A Simulation Model Comparing Olanzapine, Risperidone and Haloperidol

By Almond S.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 383-389

Adis International

Access to resources Recommend Favorite

A meta-analysis comparing the effectiveness of buprenorphine and methadone

By West S.L.   O'Neal K.K.   Graham C.W.  

Journal of Substance Abuse, Vol. 12, Iss. 4, 2000-12 ,pp. : 405-414

Elsevier

Access to resources Recommend Favorite

Efficacy and Tolerability of Nebivolol Compared with Other Antihypertensive Drugs: A Meta-Analysis

By Van Bortel Luc M.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 35-44

Adis International

Access to resources Recommend Favorite